Quick Ratios
Quarterly Results
Profit & Loss
Balance Sheet
Cash Flow
Ratios
Mkt Cap
Market Capitalization
₹151Cr
Rev Gr TTM
Revenue Growth TTM
9.28%
Peer Comparison
Compare up to 10 companies side by side across valuation, profitability, and growth.

MITSU
VS
| Quarter | Mar 2023 | Jun 2023 | Sep 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|
|
Growth YoY Revenue Growth YoY% | 11.5 | -5.7 | 8.9 | 2.5 | -1.1 | 0.5 | 7.2 | 9.5 | 10.0 | 6.4 | 13.8 | 6.9 |
| 76 | 75 | 70 | 66 | 75 | 75 | 76 | 75 | 82 | 80 | 87 | 76 |
Operating Profit Operating ProfitCr |
| 9.1 | 6.3 | 7.2 | 10.5 | 9.1 | 6.0 | 5.8 | 6.8 | 9.1 | 5.9 | 6.4 | 11.2 |
Other Income Other IncomeCr | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Expense Interest ExpenseCr | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Depreciation DepreciationCr | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 4 | 2 | 2 | 4 | 4 | 2 | 2 | 2 | 5 | 2 | 3 | 6 |
| 1 | 0 | 1 | 1 | 1 | 0 | 0 | 1 | 1 | 0 | 1 | 2 |
|
Growth YoY PAT Growth YoY% | 0.0 | -73.8 | -2.6 | 75.7 | -14.2 | -19.3 | -24.0 | -53.5 | 25.1 | 20.2 | 64.9 | 218.2 |
| 4.0 | 1.7 | 2.0 | 4.3 | 3.4 | 1.4 | 1.4 | 1.8 | 3.9 | 1.5 | 2.0 | 5.5 |
| 2.6 | 1.1 | 1.2 | 2.6 | 2.3 | 0.8 | 0.8 | 1.1 | 2.6 | 1.0 | 1.4 | 3.5 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|
|
| | 6.0 | 19.2 | 11.1 | 11.1 | 28.7 | 44.5 | 19.9 | 0.7 | 6.8 | 6.6 |
| 81 | 86 | 103 | 114 | 123 | 155 | 232 | 282 | 286 | 309 | 325 |
Operating Profit Operating ProfitCr |
| 9.2 | 8.9 | 8.6 | 8.4 | 11.4 | 12.9 | 10.0 | 8.6 | 8.3 | 7.0 | 8.1 |
Other Income Other IncomeCr | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 0 |
Interest Expense Interest ExpenseCr | 4 | 4 | 4 | 4 | 6 | 6 | 6 | 7 | 9 | 7 | 6 |
Depreciation DepreciationCr | 2 | 2 | 2 | 2 | 4 | 4 | 5 | 5 | 6 | 7 | 7 |
| 3 | 3 | 4 | 4 | 6 | 14 | 16 | 15 | 12 | 10 | 15 |
| 1 | 1 | 1 | 1 | 2 | 4 | 5 | 3 | 3 | 3 | 4 |
|
| | 27.7 | 42.5 | 3.4 | 10.7 | 143.7 | 18.7 | 2.6 | -24.9 | -18.2 | 57.8 |
| 2.1 | 2.6 | 3.1 | 2.9 | 2.9 | 5.4 | 4.5 | 3.8 | 2.9 | 2.2 | 3.2 |
| 4.9 | 2.2 | 3.1 | 1.0 | 3.2 | 7.8 | 9.3 | 9.5 | 7.1 | 5.4 | 8.4 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|
Equity Capital Equity CapitalCr | 1 | 4 | 4 | 4 | 12 | 12 | 12 | 12 | 13 | 14 | 14 |
| 9 | 9 | 18 | 23 | 18 | 28 | 39 | 50 | 67 | 83 | 86 |
Current Liabilities Current LiabilitiesCr | 28 | 28 | 27 | 40 | 44 | 48 | 58 | 70 | 84 | 80 | 81 |
Non Current Liabilities Non Current LiabilitiesCr | 17 | 15 | 20 | 32 | 33 | 37 | 35 | 45 | 31 | 18 | 15 |
Total Liabilities Total LiabilitiesCr |
Current Assets Current AssetsCr | 33 | 31 | 37 | 40 | 45 | 58 | 79 | 89 | 101 | 100 | 101 |
Non Current Assets Non Current AssetsCr | 23 | 25 | 32 | 59 | 63 | 67 | 66 | 88 | 93 | 96 | 96 |
Total Assets Total AssetsCr |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Operating Cash Flow Operating Cash FlowCr | 14 | 4 | 6 | 18 | 4 | 13 | 7 | 22 | 9 | 15 |
Investing Cash Flow Investing Cash FlowCr | -4 | -4 | -7 | -30 | -8 | -7 | -3 | -27 | -12 | -8 |
Financing Cash Flow Financing Cash FlowCr | -5 | -6 | 2 | 11 | 3 | -5 | -2 | 3 | 3 | -7 |
|
Free Cash Flow Free Cash FlowCr | 11 | 0 | -2 | -12 | -3 | 7 | 2 | -6 | -3 | 7 |
| 716.8 | 176.0 | 167.1 | 499.5 | 110.6 | 135.9 | 58.0 | 186.3 | 105.5 | 209.1 |
CFO To EBITDA CFO To EBITDA% | 167.9 | 50.9 | 60.3 | 170.0 | 27.7 | 57.0 | 26.0 | 82.7 | 36.4 | 65.1 |
| Financial Year | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|
Valuation Ratios Valuation Ratios |
Market Cap Market CapitalizationCr | 0 | 62 | 55 | 69 | 83 | 133 | 303 | 176 | 188 | 115 |
Price To Earnings Price To Earnings | 0.0 | 25.5 | 15.9 | 19.2 | 20.8 | 13.7 | 26.3 | 14.9 | 21.1 | 15.8 |
Price To Sales Price To Sales | 0.0 | 0.7 | 0.5 | 0.6 | 0.6 | 0.7 | 1.2 | 0.6 | 0.6 | 0.3 |
Price To Book Price To Book | 0.0 | 4.9 | 2.5 | 2.6 | 2.7 | 3.4 | 5.9 | 2.8 | 2.4 | 1.2 |
| 3.1 | 10.9 | 8.8 | 11.0 | 8.7 | 8.5 | 14.3 | 9.5 | 10.4 | 7.9 |
Profitability Ratios Profitability Ratios |
| 32.5 | 34.5 | 35.6 | 35.4 | 43.5 | 41.6 | 36.3 | 33.9 | 34.9 | 36.2 |
| 9.2 | 8.9 | 8.6 | 8.4 | 11.4 | 12.9 | 10.0 | 8.6 | 8.3 | 7.0 |
| 2.1 | 2.6 | 3.1 | 2.9 | 2.9 | 5.4 | 4.5 | 3.8 | 2.9 | 2.2 |
| 15.3 | 15.8 | 15.0 | 11.0 | 13.9 | 19.1 | 18.6 | 15.5 | 13.0 | 10.2 |
| 18.6 | 19.2 | 16.0 | 13.5 | 13.2 | 24.4 | 22.6 | 18.9 | 11.2 | 7.5 |
| 3.4 | 4.3 | 5.0 | 3.6 | 3.7 | 7.8 | 8.0 | 6.7 | 4.6 | 3.7 |
Operational Ratios Operational Ratios |
Solvency Ratios Solvency Ratios |
Liquidity Ratios Liquidity Ratios |
### **Overview**
Mitsu Chem Plast Limited (BSE: 540078) is a leading Indian manufacturer of polymer-based blow-molded and injection-molded plastic products, specializing in technically advanced, customized, and sustainable solutions. With over **35 years of industry experience**, the company has evolved from a single-unit operation in 1990 into a multi-facility, export-oriented enterprise serving global OEM clients across pharmaceuticals, healthcare, FMCG, chemicals, automotive, and infrastructure sectors.
---
### **Business Segments & Product Portfolio**
Mitsu Chem Plast operates across four core verticals:
1. **Molded Industrial Packaging** (dominant segment – ~86% of revenue)
- Products: Drums, jerry cans, bottles, jars (100 mL to 250 L), pails, totes, pallets, caps, closures (GL 45, TSV 40), and accessories.
- Serves: Chemicals, pharmaceuticals, food & beverage, agrochemicals, lube oil, FMCG, and specialty chemicals industries.
- Recent launches:
- **Pail Container** – Leak-proof, stackable design for liquids, powders, and solids.
- **MiEcoPET** (May 2024) – Sustainable packaging with 30–60% recycled PET; reduces raw material use by 30–50% vs. HDPE.
2. **Hospital & Healthcare Furniture Components** (11–12% of revenue; fast-growing)
- Products: Bed panels, bedside lockers, siderails, IV stands, CPR/spine boards, over-bed tables, and trolleys.
- Served via **Furnastra**, a dedicated brand launched in FY24–25 to strengthen market identity in healthcare.
- Key innovation: **Patented CPR-enabled profile** built into the back of hospital bed components for emergency resuscitation.
3. **Medical Devices**
- Products: Pregnancy kits, malaria/HIV diagnostic kits, inhalers – compliant with regulated healthcare markets.
4. **Infrastructure & Automotive Components**
- **Infrastructure**: Chair shells for schools, buses, stadiums, and public institutions.
- **Automotive**: Washer tanks, rainhoods, air ducts, filters.
---
### **Strategic Initiatives & Growth Drivers**
#### **1. Furnastra – Dedicated Healthcare Brand**
- Launched in May 2025 and publicly unveiled at **Arab Health, Dubai (Jan 2025)**.
- Focus: Durable, ergonomic, customizable, and patient-centric hospital furniture solutions.
- Achieved **over 60% domestic market share in ABS panels for hospital furniture**.
- Targeting both domestic and international expansion in healthcare, especially via export participation in **MEDICA, Arab Health, and WXH**.
#### **2. Export Growth & Global Expansion**
- **Exports to 17+ countries** (USA, UK, Germany, UAE, Saudi Arabia, Japan, Spain, Poland, Malaysia, Maldives, etc.).
- **144% YoY export growth in FY25** – primarily driven by hospital furniture parts and industrial packaging.
- Expanding presence in:
- **Middle East & North Africa**: UAE, Saudi Arabia, Egypt, Kuwait.
- **Europe**: UK, Germany, France, Spain, Poland.
- **Asia & Americas**: USA, Israel, Turkey, Maldives.
- Participating in major global trade fairs to enhance visibility and secure OEM client partnerships.
#### **3. Capacity Expansion & Manufacturing Excellence**
- **Three manufacturing units** in Maharashtra:
- **Tarapur (Boisar)**: Two units (20,000 sq. ft. and 36,000 sq. ft.).
- **Khalapur**: 96,000 sq. ft. state-of-the-art facility established in 2018–19.
- **Total manufacturing footprint**: Over **152,000 sq. ft.**.
- **Installed capacity**:
- **28,424 MT/year → 29,079 MT/year (Nov 2025)** – a 655 MT increase.
- Fully funded via internal accruals (₹85 lakh investment).
- Enhanced by **51 blow molding machines** and **18 injection molding machines (60–450 tonnes clamping force)**.
- Supports faster scaling of new products and reduced turnaround times.
#### **4. R&D & Innovation**
- Strong in-house **R&D team** focused on:
- Sustainable product development (e.g., MiEcoPET).
- Import substitution in line with **‘Make in India’**.
- Designing customized solutions for regulated markets (pharma, healthcare).
- Pipeline includes stackable PET containers for lubricants, paints, and FMCG sectors.
#### **5. Distribution & Supply Chain**
- **Dedicated depots** in Hyderabad (South India) and Delhi (North India) for efficient logistics.
- Nationwide distribution from Jammu to Chennai.
- Distributor network supports pan-India service.
---
### **Financial Highlights (FY25)**
- **Revenue**: ₹332.28 crore (up from ₹100 crore in FY15).
- **Revenue Mix**:
- Molded Industrial Packaging: **86.19%** (₹286.39 crore)
- Hospital Furniture Parts: **11.55%** (₹38.38 crore)
- Infrastructure & Others: **2.26%** (₹7.51 crore)
- **Export Revenue**: ₹140.08 lakhs in FY24–25 (rapidly growing).
---
### **Corporate Profile**
- **Founded**: 1990 (Tarapur, Maharashtra)
- **Headquarters**: Maharashtra, India
- **Listed**: BSE SME (2016) → Migrated to **BSE Main Board (2020)**
- **Certifications**: Certified polymer manufacturer with **in-house testing and QC systems**.
- **Client Base**: **Over 500 customers**, including **30+ Fortune 500 companies** in India.
- **Workforce & Expertise**: Supported by experienced professionals in manufacturing, R&D, and quality assurance.
---
### **Key Challenges & Responses**
- **Raw Material Volatility**: HDPE, PP, and filled PP costs linked to crude oil.
- Strategy: Monthly pricing adjustments; 80–90% pass-through to customers.
- **Export Logistics**: Bulkiness of products makes shipping costly.
- Strategy: Focus on high-value, lower-bulk components (e.g., medical kits, furniture parts).
- **New Market Entry**: Pail container segment has high barriers.
- Status: Secured small orders; pursuing large OEM onboarding.
---